CIK 0001730463 · Non-accelerated filer<br>Smaller reporting company
Autolus Therapeutics plc
Sign in to watch- Ticker
- AUTL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 20 3829 6230
- Business address
- THE MEDIAWORKS, 191 WOOD LANE, LONDON, United Kingdom, W12 7FP
- Former names
- Autolus Therapeutics Ltd
- SC 13G/A Stake Amended Statement of Ownership
- 6-K Event Report of Foreign Issuer
- SC 13D Stake Beneficial Ownership Report
- 424B5 Offering Prospectus
- 6-K Event Report of Foreign Issuer
- 424B5 Offering Prospectus
- 6-K Event Report of Foreign Issuer
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 6-K Event Report of Foreign Issuer
- SC 13G/A Stake Amended Statement of Ownership
- EFFECT Other Notice of Effectiveness
- 424B5 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- F-3 Offering F-3
- 6-K Event Report of Foreign Issuer
Page 14 of 17 · 340 filings